期刊文献+

土贝母皂苷对转染绿色荧光蛋白基因人乳腺癌细胞MDA-MB-231(GFP)、MCF-7(GFP)的作用 被引量:7

Effects of Tubeimoside on Human Breast Cancer Cell Lines MDA-MB-231 and MCF-7 Transfected With Green Fluorescent Protein
原文传递
导出
摘要 目的观察土贝母皂苷对转染绿色荧光蛋白(GFP)基因的人乳腺癌细胞MDA-MB-231、MCF-7的体外抗肿瘤活性。方法采用倒置光学显微镜观察土贝母皂苷作用下转染GFP基因的乳腺癌细胞MDAMB-231、MCF-7形态学变化,MTT法检测土贝母皂苷对两种乳腺癌细胞的生长抑制作用。结果土贝母皂苷作用24h后,两种人乳腺癌细胞均表现出典型凋亡形态改变;MTT结果显示土贝母皂苷对两种乳腺癌细胞的生长具有强抑制作用,MDA-MB-231(GFP)、MCF-7(GFP)经土贝母皂苷作用48h后的IC50分别为(17.03±3.22)、(27.96±0.34)μg/ml。结论土贝母皂苷对两种人乳腺癌细胞均有较强的抑制作用。 Objective To research the antitumor activity in vitro of tubeimoside on human breast cancer cell lines MDA-MB-231 and MCF-7 transfeeted with green fluorescent protein (GFP). Methods The morphological changes of MDA-MB-231 (GFP) and MCF-7 (GFP) under the action of tubeimoside were observed with inverted mi- croscope. The inhibitory effect of tubeimoside on the growth of MDA-MB-231 (GFP) and MCF-7 (GFP) were meas- ured by MTT assay. Results A typical apoptosis of MDA-MB-231 (GFP) and MCF-7 (GFP) were shown 24 hours later. MTY assay showed that tubeimoside had a strong inhibitory effect on the growth of MDA-MB-231 (GFP) and MCF-7 (GFP). The inhibitory concentration 50 (IC50) of MDA-MB-231 (GFP) and MCF-7 (GFP) was ( 17.03 ± 3.22) μg/ml and (27.96±0. 34 ) μg/ml respectively 48 hours later. Conclusion Tubeimoside has a strong inhibitory effect on the growth of MDA-MB-231 (GFP) and MCF-7 (GFP)
出处 《中医杂志》 CSCD 北大核心 2014年第13期1136-1138,共3页 Journal of Traditional Chinese Medicine
基金 科技部国际科技合作项目(2009DFA31490) 北京中医药大学自主选题项目(2009ZYBZZ-JS089)
关键词 土贝母皂苷 绿色荧光蛋白 MDA-MB-231 MCF-7 凋亡 tubeimoside green fluorescent protein MDA-MB-231 MCF-7 apoptosis
  • 相关文献

参考文献7

二级参考文献19

  • 1马润娣,于立坚,王永清,西野辅翼.土贝母甙甲抗肿瘤活性的研究[J].中国肿瘤临床,1994,21(6):446-446. 被引量:20
  • 2周亮,黄焰.乳腺癌药物预防及相关情况新进展[J].癌症进展,2007,5(2):163-167. 被引量:9
  • 3万霞,刘建平.临床研究中的样本量估算:(2)观察性研究[J].中医杂志,2007,48(7):599-601. 被引量:74
  • 4中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治规范·肿瘤诊治工作常用统计指标和统计方法[M].北京:北京医科大学、中国协和医科大学联合出版社,1991:10-15.
  • 5Rakha EA, Ellis IO. Triple-negative/basal-like breast cancer: review[J]. Pathology, 2009, 41(1) :40 - 47.
  • 6Lund MJ,Butler EN, Bumpers H L, et al. Highpreva- lence of triple-negative tumors in an urban cancercenter [J]. Cancer, 2008,113(3) :608 - 615.
  • 7Gerson R,Alban F, Villalobos A, et al. Recurrence and survival rates among early breast cancer cases with triple- negative immunophenotype[J]. Gac Med Mex, 2008,144 (1):27-34.
  • 8Liu ZB,Liu GY, Yang WT, et al. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients[J]. Oncol Rep, 2008,20(4):987 - 994.
  • 9Dent R, Hanna WM,Trudeau M, et al. Pattern of meta- static spread in triple-negative breast cancer [J]. Breast Cancer Res Treat,2009,115(2):423- 428.
  • 10Rakha EA,E1-Sayed M. E, Green AR. Prognostic mark- ers in triple-negative breast cancer[J]. Cancer, 2007,109 (1):25-32.

共引文献55

同被引文献130

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部